Back to results
US 4,393,208 AGranted
5-Methyl-2-trifluoromethylindolo[2,3-b]quinoxaline
AssigneeNorwich Eaton Pharmaceuticals, Inc.
InventorRobert J. Alaimo
Life of this patent
Estimating the term…
Abstract
The compound 5-methyl-2-trifluoromethylindolo[2,3-b]quinoxaline is useful as an immunomodulating agent.
Claims1
The compound 5-methyl-2-trifluoromethylindolo[2,3-b]quinoxaline.
Dependencies are inferred from the claim text.